Recent findings, including the CONVINCE study report, suggests the superiority of high-
volume hemodiafiltration over high-flux hemodialysis in improving patients' outcomes …

This review provides a detailed analysis of hemodiafiltration (HDF), its progress from an
emerging technique to a potential conventional treatment for chronic hemodialysis patients …

The CONVINCE trial demonstrates that high-dose hemodiafiltration offers a survival
advantage for patients in the high-flux hemodiafiltration group compared to hemodialysis …

Despite significant medical and technical improvements in the field of dialysis, the morbidity
and mortality among patients with chronic kidney disease (CKD) stage 5 on dialysis remains …

Inadequate clearance of protein-bound uremic toxins (PBUTs) during dialysis is associated
with morbidities in chronic kidney disease patients. The development of high-permeance …

Background A kinetic model for beta-2-microglobulin removal and generation was used to
explore the impact of adding hemodiafiltration on predialysis and time-averaged serum …

Background Debate continues as to the optimum hemodialysis (HD) dialysate calcium
concentration. Although current guidelines advocate 1.25–1.5 mmol/L, some investigators …

Chronic kidney diseases-associated pruritus (CKD-aP) is a term that indicates the itching
associated to end stage kidney disease without any apparent cause. This symptom leads to …

Abstract Rationale & Objective The use of hemodiafiltration (HDF) as a kidney replacement
therapy (KRT) in patients with end-stage kidney disease (ESKD) has sparked a debate …

The CONVINCE study, recently published in the New England Journal of Medicine, reveals
a groundbreaking 23% reduction in the relative risk of all-cause mortality among end-stage …